Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study

• Hoofdauteurs: Lucia Caminiti (Auteur), Francesca Galletta (Auteur), Simone Foti Randazzese (Auteur), Paolo Barraco (Auteur), Stefano Passanisi (Auteur), Antonella Gambadauro (Auteur), Giuseppe Crisafulli (Auteur), Mariella Valenzise (Auteur), Sara Manti (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2024-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Despite the increasing interest in biologics for the management of allergic diseases, sparse real-world data are still available in the pediatric population. This study aimed to evaluate the early real-life efficacy and safety of omalizumab for patients with moderate-to-severe asthma and...